Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan

Hiam Abdala-Valencia, Sergejs Berdnikovs, Christine A. McCary, Daniela Urick, Riti Mahadevia, Michelle E. Marchese, Kelsey Swartz, Lakiea Wright, Gökhan M. Mutlu, Joan M. Cook-Mills

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Clinical reports indicate that patients with allergy/asthma commonly have associated symptoms of anxiety/depression. Anxiety/depression can be reduced by 5-hydroxytryptophan (5-HTP) supplementation. However, it is not known whether 5-HTP reduces allergic inflammation. Therefore, we determined whether 5-HTP supplementation reduces allergic inflammation. We also determined whether 5-HTP decreases passage of leukocytes through the endothelial barrier by regulating endothelial cell function. For these studies, C57BL/6 mice were supplemented with 5-HTP, treated with ovalbumin fraction V (OVA), house dust mite (HDM) extract, or IL-4, and examined for allergic lung inflammation and OVA-induced airway responsiveness. To determine whether 5-HTP reduces leukocyte or eosinophil transendothelial migration, endothelial cells were pretreated with 5-HTP, washed and then used in an in vitro transendothelial migration assay under laminar flow. Interestingly, 5-HTP reduced allergic lung inflammation by 70-90% and reduced antigen-induced airway responsiveness without affecting body weight, blood eosinophils, cytokines, or chemokines. 5-HTP reduced allergen-induced transglutaminase 2 (TG2) expression and serotonylation (serotonin conjugation to proteins) in lung endothelial cells. Consistent with the regulation of endothelial serotonylation in vivo, in vitro pretreatment of endothelial cells with 5-HTP reduced TNF-a-induced endothelial cell serotonylation and reduced leukocyte transendothelial migration. Furthermore, eosinophil and leukocyte transendothelial migration was reduced by inhibitors of transglutaminase and by inhibition of endothelial cell serotonin synthesis, suggesting that endothelial cell serotonylation is key for leukocyte transendothelial migration. In summary, 5-HTP supplementation inhibits endothelial serotonylation, leukocyte recruitment, and allergic inflammation. These data identify novel potential targets for intervention in allergy/asthma.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume303
Issue number8
DOIs
StatePublished - Oct 26 2012

Fingerprint

5-Hydroxytryptophan
Inflammation
Transendothelial and Transepithelial Migration
Endothelial Cells
Leukocytes
Eosinophils
Serotonin
Pneumonia
Hypersensitivity
Inhibition (Psychology)
Asthma
Anxiety
Depression
Pyroglyphidae
Transglutaminases
Ovalbumin
Inbred C57BL Mouse
Chemokines
Interleukin-4
Allergens

Keywords

  • 5-hydroxytryptophan metabolites
  • Endothelial cell
  • Leukocyte recruitment
  • Lung
  • Serotonylation

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Abdala-Valencia, Hiam ; Berdnikovs, Sergejs ; McCary, Christine A. ; Urick, Daniela ; Mahadevia, Riti ; Marchese, Michelle E. ; Swartz, Kelsey ; Wright, Lakiea ; Mutlu, Gökhan M. ; Cook-Mills, Joan M. / Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2012 ; Vol. 303, No. 8.
@article{09f21bbaf5b542a4bf07cc3c5d9ba5d1,
title = "Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan",
abstract = "Clinical reports indicate that patients with allergy/asthma commonly have associated symptoms of anxiety/depression. Anxiety/depression can be reduced by 5-hydroxytryptophan (5-HTP) supplementation. However, it is not known whether 5-HTP reduces allergic inflammation. Therefore, we determined whether 5-HTP supplementation reduces allergic inflammation. We also determined whether 5-HTP decreases passage of leukocytes through the endothelial barrier by regulating endothelial cell function. For these studies, C57BL/6 mice were supplemented with 5-HTP, treated with ovalbumin fraction V (OVA), house dust mite (HDM) extract, or IL-4, and examined for allergic lung inflammation and OVA-induced airway responsiveness. To determine whether 5-HTP reduces leukocyte or eosinophil transendothelial migration, endothelial cells were pretreated with 5-HTP, washed and then used in an in vitro transendothelial migration assay under laminar flow. Interestingly, 5-HTP reduced allergic lung inflammation by 70-90{\%} and reduced antigen-induced airway responsiveness without affecting body weight, blood eosinophils, cytokines, or chemokines. 5-HTP reduced allergen-induced transglutaminase 2 (TG2) expression and serotonylation (serotonin conjugation to proteins) in lung endothelial cells. Consistent with the regulation of endothelial serotonylation in vivo, in vitro pretreatment of endothelial cells with 5-HTP reduced TNF-a-induced endothelial cell serotonylation and reduced leukocyte transendothelial migration. Furthermore, eosinophil and leukocyte transendothelial migration was reduced by inhibitors of transglutaminase and by inhibition of endothelial cell serotonin synthesis, suggesting that endothelial cell serotonylation is key for leukocyte transendothelial migration. In summary, 5-HTP supplementation inhibits endothelial serotonylation, leukocyte recruitment, and allergic inflammation. These data identify novel potential targets for intervention in allergy/asthma.",
keywords = "5-hydroxytryptophan metabolites, Endothelial cell, Leukocyte recruitment, Lung, Serotonylation",
author = "Hiam Abdala-Valencia and Sergejs Berdnikovs and McCary, {Christine A.} and Daniela Urick and Riti Mahadevia and Marchese, {Michelle E.} and Kelsey Swartz and Lakiea Wright and Mutlu, {G{\"o}khan M.} and Cook-Mills, {Joan M.}",
year = "2012",
month = "10",
day = "26",
doi = "10.1152/ajplung.00406.2011",
language = "English (US)",
volume = "303",
journal = "American Journal of Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "8",

}

Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan. / Abdala-Valencia, Hiam; Berdnikovs, Sergejs; McCary, Christine A.; Urick, Daniela; Mahadevia, Riti; Marchese, Michelle E.; Swartz, Kelsey; Wright, Lakiea; Mutlu, Gökhan M.; Cook-Mills, Joan M.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 303, No. 8, 26.10.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan

AU - Abdala-Valencia, Hiam

AU - Berdnikovs, Sergejs

AU - McCary, Christine A.

AU - Urick, Daniela

AU - Mahadevia, Riti

AU - Marchese, Michelle E.

AU - Swartz, Kelsey

AU - Wright, Lakiea

AU - Mutlu, Gökhan M.

AU - Cook-Mills, Joan M.

PY - 2012/10/26

Y1 - 2012/10/26

N2 - Clinical reports indicate that patients with allergy/asthma commonly have associated symptoms of anxiety/depression. Anxiety/depression can be reduced by 5-hydroxytryptophan (5-HTP) supplementation. However, it is not known whether 5-HTP reduces allergic inflammation. Therefore, we determined whether 5-HTP supplementation reduces allergic inflammation. We also determined whether 5-HTP decreases passage of leukocytes through the endothelial barrier by regulating endothelial cell function. For these studies, C57BL/6 mice were supplemented with 5-HTP, treated with ovalbumin fraction V (OVA), house dust mite (HDM) extract, or IL-4, and examined for allergic lung inflammation and OVA-induced airway responsiveness. To determine whether 5-HTP reduces leukocyte or eosinophil transendothelial migration, endothelial cells were pretreated with 5-HTP, washed and then used in an in vitro transendothelial migration assay under laminar flow. Interestingly, 5-HTP reduced allergic lung inflammation by 70-90% and reduced antigen-induced airway responsiveness without affecting body weight, blood eosinophils, cytokines, or chemokines. 5-HTP reduced allergen-induced transglutaminase 2 (TG2) expression and serotonylation (serotonin conjugation to proteins) in lung endothelial cells. Consistent with the regulation of endothelial serotonylation in vivo, in vitro pretreatment of endothelial cells with 5-HTP reduced TNF-a-induced endothelial cell serotonylation and reduced leukocyte transendothelial migration. Furthermore, eosinophil and leukocyte transendothelial migration was reduced by inhibitors of transglutaminase and by inhibition of endothelial cell serotonin synthesis, suggesting that endothelial cell serotonylation is key for leukocyte transendothelial migration. In summary, 5-HTP supplementation inhibits endothelial serotonylation, leukocyte recruitment, and allergic inflammation. These data identify novel potential targets for intervention in allergy/asthma.

AB - Clinical reports indicate that patients with allergy/asthma commonly have associated symptoms of anxiety/depression. Anxiety/depression can be reduced by 5-hydroxytryptophan (5-HTP) supplementation. However, it is not known whether 5-HTP reduces allergic inflammation. Therefore, we determined whether 5-HTP supplementation reduces allergic inflammation. We also determined whether 5-HTP decreases passage of leukocytes through the endothelial barrier by regulating endothelial cell function. For these studies, C57BL/6 mice were supplemented with 5-HTP, treated with ovalbumin fraction V (OVA), house dust mite (HDM) extract, or IL-4, and examined for allergic lung inflammation and OVA-induced airway responsiveness. To determine whether 5-HTP reduces leukocyte or eosinophil transendothelial migration, endothelial cells were pretreated with 5-HTP, washed and then used in an in vitro transendothelial migration assay under laminar flow. Interestingly, 5-HTP reduced allergic lung inflammation by 70-90% and reduced antigen-induced airway responsiveness without affecting body weight, blood eosinophils, cytokines, or chemokines. 5-HTP reduced allergen-induced transglutaminase 2 (TG2) expression and serotonylation (serotonin conjugation to proteins) in lung endothelial cells. Consistent with the regulation of endothelial serotonylation in vivo, in vitro pretreatment of endothelial cells with 5-HTP reduced TNF-a-induced endothelial cell serotonylation and reduced leukocyte transendothelial migration. Furthermore, eosinophil and leukocyte transendothelial migration was reduced by inhibitors of transglutaminase and by inhibition of endothelial cell serotonin synthesis, suggesting that endothelial cell serotonylation is key for leukocyte transendothelial migration. In summary, 5-HTP supplementation inhibits endothelial serotonylation, leukocyte recruitment, and allergic inflammation. These data identify novel potential targets for intervention in allergy/asthma.

KW - 5-hydroxytryptophan metabolites

KW - Endothelial cell

KW - Leukocyte recruitment

KW - Lung

KW - Serotonylation

UR - http://www.scopus.com/inward/record.url?scp=84867735503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867735503&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00406.2011

DO - 10.1152/ajplung.00406.2011

M3 - Article

VL - 303

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1040-0605

IS - 8

ER -